Enoxaparin sodium biosimilar (Pharmathen)

依诺肝素钠生物类似药(Pharmathen)

Report date: 2025/07/25 17:36:37

Base Information

Drug NameEnoxaparin sodium biosimilar (Pharmathen)
Drug Alias NameEnoxaparina de sodio (Pharmathen)Enoxaparinum natricum (Pharmathen)Thorinane
ClassificationBiologics > BiosimilarNatural product/Extract > Animal extract
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsVenous Thromboembolism
Global Approved IndicationsVenous Thromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2016/09/14
Country/TerritoryEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPharmathen Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsVenous Thromboembolism

Other Information

ATC CodeB01AB05
Related LinksN/A